Department of Internal Medicine, Division of Hematology/Oncology, College of Medicine, University of Cincinnati, 3125 Eden Avenue, Cincinnati, OH 45267, USA.
Curr Opin Genet Dev. 2013 Feb;23(1):63-71. doi: 10.1016/j.gde.2013.02.001. Epub 2013 Mar 13.
Ribosome biogenesis and protein synthesis are two of the most energy consuming processes in a growing cell. Moreover, defects in their molecular components can alter the pattern of gene expression. Thus it is understandable that cells have developed a surveillance system to monitor the status of the translational machinery. Recent discoveries of causative mutations and deletions in genes linked to ribosome biogenesis have defined a group of similar pathologies termed ribosomopathies. Over the past decade, much has been learned regarding the relationship between growth control and ribosome biogenesis. The discovery of extra-ribosomal functions of several ribosome proteins and their regulation of p53 levels has provided a link from ribosome impairment to cell cycle regulation. Yet, evidence suggesting p53 and/or Hdm2 independent pathways also exists. In this review, we summarize recent advances in understanding the mechanisms underlying the pathologies of ribosomopathies and discuss the relationship between ribosome production and tumorigenesis.
核糖体生物发生和蛋白质合成是生长细胞中最耗能的两个过程。此外,其分子成分的缺陷会改变基因表达模式。因此,可以理解的是,细胞已经开发出一种监控系统来监测翻译机制的状态。最近在与核糖体生物发生相关的基因中发现了致病突变和缺失,这定义了一组称为核糖体病的类似疾病。在过去的十年中,人们已经了解了生长控制和核糖体生物发生之间的关系。几个核糖体蛋白的核糖体外功能及其对 p53 水平的调节的发现,为核糖体损伤与细胞周期调节之间提供了联系。然而,也存在证据表明存在 p53 和/或 Hdm2 独立途径。在这篇综述中,我们总结了理解核糖体病病理学基础的机制的最新进展,并讨论了核糖体产生与肿瘤发生之间的关系。